Audax acquires CRO Altasciences from Kilmer Capital Partners

U.S. private equity firm Audax Private Equity has acquired Altasciences Company Inc, a Laval, Québec-based early-phase clinical research organization operating across North America. No financial terms were disclosed for the deal, which was done by Audax in partnership with the company’s management. The seller is Canadian private equity firm Kilmer Capital Partners, which invested in Altasciences in 2007. Altasciences combines Algorithme Pharma, Vince & Associates and Algorithme Pharma USA.

DealsNorth AmericaUSBriefs